Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Braskem S.A. ADR (NYSE: BAK) closed at $2.45 down -2.39% from its previous closing price of $2.51. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.53 million shares were traded. BAK stock price reached its highest trading level at $2.53 during the session, while it also had its lowest trading level at $2.44.
Ratios:
For a deeper understanding of Braskem S.A. ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.68 and its Current Ratio is at 1.21.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 1063649344 and an Enterprise Value of 57566158848. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.03. Its current Enterprise Value per Revenue stands at 0.741 whereas that against EBITDA is 23.612.
Stock Price History:
The Beta on a monthly basis for BAK is 1.81, which has changed by -0.59120524 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, BAK has reached a high of $6.34, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is -15.22%, while the 200-Day Moving Average is calculated to be -30.08%.
Shares Statistics:
For the past three months, BAK has traded an average of 1.07M shares per day and 968410 over the past ten days. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of 1760486400 were 2972780 with a Short Ratio of 2.79, compared to 1757894400 on 3161073. Therefore, it implies a Short% of Shares Outstanding of 2972780 and a Short% of Float of 3.1300000000000003.
Earnings Estimates
A comprehensive evaluation of Braskem S.A. ADR (BAK) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$1.19, with high estimates of -$1.19 and low estimates of -$1.19.
Analysts are recommending an EPS of between $0.4 and -$0.51 for the fiscal current year, implying an average EPS of -$0.06. EPS for the following year is -$0.65, with 2.0 analysts recommending between -$0.48 and -$0.83.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $17.34B this quarter.It ranges from a high estimate of $18.28B to a low estimate of $16.45B. As of. The current estimate, Braskem S.A. ADR’s year-ago sales were $21.27BFor the next quarter, 4 analysts are estimating revenue of $17.78B. There is a high estimate of $18.23B for the next quarter, whereas the lowest estimate is $17.12B.
A total of 10 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $79.61B, while the lowest revenue estimate was $69.97B, resulting in an average revenue estimate of $74.38B. In the same quarter a year ago, actual revenue was $77.41BBased on 10 analysts’ estimates, the company’s revenue will be $80.51B in the next fiscal year. The high estimate is $87.7B and the low estimate is $73.91B.
